Drug General Information
Drug ID	D0SQ1T
Former ID	DNC010937
Drug Name	2,5-dideoxy-2,5-imino-D-altritol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[530905]
Structure		Download 2D MOL 3D MOL
Formula	C6H13NO4
Canonical SMILES	C(C1C(C(C(N1)CO)O)O)O
InChI	1S/C6H13NO4/c8-1-3-5(10)6(11)4(2-9)7-3/h3-11H,1-2H2/t3-,4-,5-,6+/m1/s1
InChIKey	PFYHYHZGDNWFIF-KAZBKCHUSA-N
PubChem Compound ID	10261406
Target and Pathway
Target(s)	Lactase-phlorizin hydrolase	Target Info	Inhibitor	[530905]
	Alpha-galactosidase A	Target Info	Inhibitor	[530905]
KEGG Pathway	Galactose metabolism
	Metabolic pathways
	Carbohydrate digestion and absorptionhsa00052:Galactose metabolism
	Glycerolipid metabolism
	Sphingolipid metabolism
	Glycosphingolipid biosynthesis - globo series
	Lysosome
PathWhiz Pathway	Lactose Degradation
	Galactose MetabolismPW000148:Sphingolipid Metabolism
	Galactose Metabolism
Reactome	Glycosphingolipid metabolism
WikiPathways	Metabolism of carbohydratesWP2788:Sphingolipid metabolism
References
Ref 530905	Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. Epub 2010 Apr 21.2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.
Ref 530905	Bioorg Med Chem. 2010 Jun 1;18(11):3790-4. Epub 2010 Apr 21.2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.